We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9005:TSETOKYU CORPORATION Analysis

Data as of 2026-03-14 - not real-time

¥1,870.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Tokyu Corp is trading at ¥1,870, comfortably above its 20‑day SMA (¥1,942) and 50‑day SMA (¥1,859) but still below the 200‑day SMA (¥1,793), indicating a short‑term bullish bias within a longer‑term uptrend. The RSI sits at 42.8, suggesting neutral momentum, while the MACD histogram is negative (‑14.5) and the signal line is bearish, warning of potential downside pressure near the current support of ¥1,857. Volatility over the past 30 days is elevated at 21.4%, yet the beta is exceptionally low (0.08), meaning the stock moves largely independent of market swings. Fundamentals show a modest 2% revenue growth and an operating margin of 11%, but the balance sheet is strained with a debt‑to‑equity ratio of 152 and no cash on hand, raising concerns about the sustainability of the 1.71% dividend (payout ratio ~18%). Analysts project a 13% upside to a target mean price of ¥2,113, supported by a fair P/E of 12.4 and P/B of 1.22, but the heavy leverage and limited free cash flow temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating near‑term downside pressure
  • Proximity to technical support at ¥1,857
  • Elevated 30‑day volatility despite low beta

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Alignment of 20‑day, 50‑day, and 200‑day SMAs in a bullish configuration
  • Projected upside of ~13% toward analyst target price
  • Moderate revenue growth and attractive dividend yield

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio and lack of cash reserves
  • Stable operating margin but zero net profit margin
  • Sector exposure to consumer cyclicals with medium risk

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
P/E Ratio12.4
Debt/Equity152.07
P/B Ratio1.2

Technical Analysis

TrendBullish
RSI42.8
Support¥1,857.00
Resistance¥2,011.00
MA 20¥1,942.35
MA 50¥1,858.58
MA 200¥1,792.75
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Target Price¥2,113.33
Upside/Downside13.01%
GradeFair
TypeBlend
Dividend Yield1.71%

Risk Assessment

Beta0.08
Volatility21.44%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.